Evozyne
Designs engineered protein therapeutics using an AI-native platform.
aibiotech
Company facts
- Founded
- 2020
- Employees
- 70
- Headquarters
- United States
- Type
- Private
- Funding
- Series B · $81M · 2023
Open positions
1 job
22 views last week
Applied AI Research Fellow
North AmericaFellowship
United States
Chicago, ILEvozyne, an AI-native biotech in Chicago, seeks a research fellow to advance its EvoGen generative protein-design platform: benchmarking generative protein models, exploring Bayesian optimization extensions for multi-objective design, and building deep learning methods (VAEs, remote homology) validated against real experimental data.
AI Deep Learning Generative AI Machine Learning